Sanofi terminates NaP2b inhibitors development deal with Ardelyx
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 03 Sep, 2015
Singapore: Sanofi has terminated NaP2b inhibitors development deal with US based Ardelyx, a clinical-stage biopharmaceut...Read more
AB SCIEX, Dalton Pharma to advance antibody drug conjugate analysis
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 27 Aug, 2014
Singapore: Global technology firm AB SCIEX and Dalton Pharma Services have formed a research collaboration to develop An...Read more
Profits - A stumbling block for Ebola research
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 16 Sep, 2014
Singapore: Global experts have commented that the lack of adequate funding was a major drawback that discouraged researc...Read more
Aussie firm to initiate oncology clinical trial in Europe
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Nov, 2014
Singapore: Australia based drug discovery company, Viralytics, has recieved UK Medicines and Healthcare Products Regulat...Read more
AMRI receives NIH contract for clinical drug product
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 23 Jan, 2015
Singapore: Clinical research firm, AMRI, has received a 10-year federal contract award from the National Institutes of H...Read more
Singapore start-up progresses in Alzheimer's drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 22 Sep, 2014
Singapore: Singapore start-up and Scotland based TauRx Therapeutics is progressing in its two Phase III clinical trials ...Read more
Novartis: Lucentis reduces AMD blindness by 50%
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 May, 2013
Singapore: Novartis revealed new clinical data associated with the eye drug Lucentis (ranibizumab) admist a total of 209...Read more
Genovate, ScinoPharm co-develop Hep B Drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Nov, 2013
Singapore: Taiwan based Genovate Biotechnology and ScinoPharm have jointly developed the highly potent oral generic drug...Read more
Roche acquires respiratory therapy firm at $8.3 bn
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 27 Aug, 2014
Singapore: Global biopharmaceutical company, Roche, has acquired InterMune, a biotechnology company focused on the resea...Read more
Neurocrine Biosciences collaborates with Mitsubishi Tanabe Pharma
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 05 Apr, 2015
Nasdaq-listed Neurocrine Biosciences has entered into an exclusive collaboration and licensing agreement for the develop...Read more
Daiichi Sankyo initiates TaNeDS drug discovery program in Europe
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 01 Oct, 2015
Tokyo: Japan's Daiichi Sankyo Company Limited has announced details of the application for its Take a New Challenge for ...Read more
Aussie firm gets FDA green flag for oncology drug
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 02 Apr, 2015
Singapore: Australia biotech firm, Prescient Therapeutics, a clinical stage oncology company, has secured agreement from...Read more
Pomalidomide Celgene gets EU nod for multiple myeloma
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 04 Jun, 2013
Singapore: European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended marketing a...Read more
Spinifex capitalizes on pain management market
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Mar, 2012
Realizing the need for improved therapies in the highly unmet field of pain management, Australia-based Spinifex has bee...Read more
Gilead's Viread patent revoked in China
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Aug, 2013
Singapore: China's State Intellectual Property Office (SIPO) has yanked the patent for Gilead Sciences popular HIV and h...Read more
Companion diagnostic drug for prostate cancer from Japan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 17 Mar, 2015
Singapore: Japan's Tokai Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing novel therapi...Read more
Biogen, Elan drug effective for multiple sclerosis
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Mar, 2013
Singapore: A study conducted on Biogen and Elan Pharmaceuticals's natalizumab has been shown to be effective for treatin...Read more
Roche, AstraZeneca form firm to share R&D data
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 27 Jun, 2013
Singapore: Roche and AstraZeneca entered into a collaboration to share early research data generated by Matched Molecula...Read more